Browsing by Author "Kocev, Nikola I (6602672952)"
Now showing 1 - 1 of 1
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Impact on long-term mortality of access and non-access site bleeding after primary percutaneous coronary intervention(2019) ;Matic, Dragan M (25959220100) ;Asanin, Milika R (8603366900) ;Vukcevic, Vladan D (15741934700) ;Mehmedbegovic, Zlatko H (55778381000) ;Marinkovic, Jelena M (7004611210) ;Kocev, Nikola I (6602672952) ;Marjanovic, Marija M (56437423000) ;Mrdovic, Igor B (10140828000) ;Antonijevic, Nebojsa M (6602303948) ;Milosevic, Aleksandra D (56622640900) ;Zivkovic, Milorad N (55959530600) ;Krljanac, Gordana V (8947929900) ;Stankovic, Sanja Dj (7005216636) ;Milasinovic, Dejan G (24823024500) ;Lasica, Ratko M (14631892300)Stankovic, Goran R (59150945500)Objectives The influence of the bleeding site on long-term survival after the primary percutaneous coronary intervention (PCI) is poorly understood. This study sought to investigate the relationship between in-hospital access site versus non-access site bleeding and very late mortality in unselected patients treated with primary PCI. Methods Data of the 2715 consecutive patients with ST-segment elevation myocardial infarction treated with primary PCI, enrolled in a prospective registry of a high volume tertiary centre, were analysed. Bleeding events were assessed according to the Bleeding Academic Research Consortium (BARC) criteria. The primary outcome was 4-year mortality. Results The BARC type ≥2 bleeding occurred in 171 patients (6.3%). Access site bleeding occurred in 3.8%, and non-access site bleeding in 2.5% of patients. Four-year mortality was significantly higher for patients with bleeding (BARC type ≥2) than in patients without bleeding (BARC type 0+1), (36.3% vs 16.2%, p<0.001). Patients with non-access site bleeding had higher 4 year mortality (50.7% vs 26.5%, p=0.001). After multivariable adjustment, BARC type ≥2 bleeding was the independent predictor of 4 year mortality (HR 2.01; 95% CI 1.49 to 2.71, p<0.001). Patients with a non-access site bleeding were at 2-fold higher risk of very late mortality than patients with an access site bleeding (HR 2.62; 1.78 to 3.86, p<0.001 vs HR 1.57; 1.03 to 2.38, p=0.034). Conclusions Both access and non-access site BARC type ≥2 bleeding is independently associated with a high risk of 4-year mortality after primary PCI. Patients with non-access site bleeding were at higher risk of late mortality than patients with access site bleeding. © 2019 Author(s) (or their employer(s)).
